FORTE BIOSCIENCES INC (FBRX) Stock Analyst Ratings
USA - NASDAQ:FBRX - US34962G2084 - Common Stock
14.785 USD
+1.28 (+9.44%)
ChartMill assigns a Buy % Consensus number of 82% to FBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 45.56. This target is 208.15% above the current price.
FBRX was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about FBRX.
In the previous month the buy percentage consensus was at a similar level.
FBRX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-18 | Guggenheim | Initiate | Buy |
| 2025-08-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-21 | TD Cowen | Initiate | Buy |
| 2024-12-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-30 | Brookline Capital | Initiate | Buy |
| 2024-04-08 | Ladenburg Thalmann | Upgrade | Neutral -> Buy |
| 2021-09-20 | Chardan Capital | Upgrade | Sell -> Neutral |
| 2021-09-03 | Chardan Capital | Downgrade | Buy -> Sell |
| 2021-09-03 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2021-09-03 | Brookline Capital | Downgrade | Buy -> Hold |
| 2021-09-03 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2021-09-03 | Truist Securities | Downgrade | Buy -> Hold |
| 2021-05-14 | B. Riley Securities | Initiate | Buy |
| 2021-03-26 | Citigroup | Initiate | Buy |
| 2021-03-17 | Chardan Capital | Maintains | Buy |